Showing results (121-130 of 130) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 130 results.
Journal for Immunotherapy of Cancer|March 29, 2022
eEF2K promotes PD-L1 stabilization through inactivating GSK3β in melanomaXisha Chen, Kuansong Wang, Shilong Jiang, et al.
The New Phytologist|November 22, 2024
Natural variation in GhROPGEF5 contributes to longer and stronger cotton fibersWenwen Wang, Dexin Liu, Tingfu Zhang, et al.
Cancer Immunology Research|November 12, 2024
Targeting of Tumoral NAC1 Mitigates Myeloid-Derived Suppressor Cell-Mediated Immunosuppression and Potentiates Anti-PD-1 Therapy in Ovarian CancerShunli Dong, Cong Ye, Bin Li, et al.
Science Translational Medicine|August 16, 2019
MDM2 antagonists overcome intrinsic resistance to CDK4/6 inhibition by inducing p21Anna E Vilgelm, Nabil Saleh, Rebecca Shattuck-Brandt, et al.
ACS Nano|April 23, 2024
Nanoparticle Retinoic Acid-Inducible Gene I Agonist for Cancer ImmunotherapyLihong Wang-Bishop, Mohamed Wehbe, Lucinda E Pastora, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 23, 2016
PI3K Inhibition Reduces Mammary Tumor Growth and Facilitates Antitumor Immunity and Anti-PD1 ResponsesJiqing Sai, Philip Owens, Sergey V Novitskiy, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 13, 2026
Superconductivity suppression and bilayer decoupling in Pr-substituted YBa2Cu3O7-δJinming Yang, Zheting Jin, Siqi Wang, et al.
World Neurosurgery|June 30, 2026
A grading system based on multiparametric MRI-predicted tumor perfusion, invasiveness and texture (GOLDS-PIT) for surgical difficulty assessment in pituitary macroadenomas: A prospective single-centre cohort studyShun Yao, Wenting Rui, Jinming Yang, et al.
Research Square|May 20, 2024
Programable Albumin-Hitchhiking Nanobodies Enhance the Delivery of STING Agonists to Potentiate Cancer ImmunotherapyJohn Wilson, Blaise Kimmel, Karan Arora, et al.
Nature Biomedical Engineering|June 11, 2025
Potentiating cancer immunotherapies with modular albumin-hitchhiking nanobody-STING agonist conjugatesBlaise R Kimmel, Karan Arora, Neil C Chada, et al.
Pageof 13